Treloar C - Search Results

1

Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study.

Valerio H, Alavi M, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Holden J, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Dore GJ, Grebely J. Valerio H, et al. Among authors: treloar c. Clin Infect Dis. 2021 Jul 1;73(1):e69-e78. doi: 10.1093/cid/ciaa571. Clin Infect Dis. 2021. PMID: 32421194 Free PMC article.

2

Receiving a hepatitis C-positive diagnosis.

Hopwood M, Treloar C. Hopwood M, et al. Among authors: treloar c. Intern Med J. 2004 Sep-Oct;34(9-10):526-31. doi: 10.1111/j.1445-5994.2004.00639.x. Intern Med J. 2004. PMID: 15482264

3

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

Doab A, Treloar C, Dore GJ. Doab A, et al. Among authors: treloar c. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S313-20. doi: 10.1086/427446. Clin Infect Dis. 2005. PMID: 15768340

4

The experience of interferon-based treatments for hepatitis C infection.

Hopwood M, Treloar C. Hopwood M, et al. Among authors: treloar c. Qual Health Res. 2005 May;15(5):635-46. doi: 10.1177/1049732304273932. Qual Health Res. 2005. PMID: 15802540

5

The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.

Hopwood M, Treloar C. Hopwood M, et al. Among authors: treloar c. Int J Drug Policy. 2007 Oct;18(5):374-80. doi: 10.1016/j.drugpo.2006.12.018. Epub 2007 Jan 23. Int J Drug Policy. 2007. PMID: 17854725

6

The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis.

Treloar C, Rhodes T. Treloar C, et al. Qual Health Res. 2009 Sep;19(9):1321-34. doi: 10.1177/1049732309341656. Qual Health Res. 2009. PMID: 19690211 Review.

7

Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.

Treloar C, Newland J, Rance J, Hopwood M. Treloar C, et al. J Viral Hepat. 2010 Dec;17(12):839-44. doi: 10.1111/j.1365-2893.2009.01250.x. J Viral Hepat. 2010. PMID: 20070504

8

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.

Grebely J, Bryant J, Hull P, Hopwood M, Lavis Y, Dore GJ, Treloar C. Grebely J, et al. Among authors: treloar c. J Viral Hepat. 2011 Apr;18(4):e104-16. doi: 10.1111/j.1365-2893.2010.01370.x. Epub 2010 Sep 14. J Viral Hepat. 2011. PMID: 20840350

9

Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.

Treloar C, Hull P, Bryant J, Hopwood M, Grebely J, Lavis Y. Treloar C, et al. Drug Alcohol Depend. 2011 Jul 1;116(1-3):52-6. doi: 10.1016/j.drugalcdep.2010.11.018. Epub 2010 Dec 30. Drug Alcohol Depend. 2011. PMID: 21194852

10

Social inclusion and hepatitis C: exploring new possibilities for prevention.

Treloar C, Valentine K, Fraser S. Treloar C, et al. Expert Rev Anti Infect Ther. 2011 Apr;9(4):397-404. doi: 10.1586/eri.11.26. Expert Rev Anti Infect Ther. 2011. PMID: 21504397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters